ALK fusions phosphorylate FRS

Stable Identifier
R-HSA-9712087
Type
Reaction
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

FRS proteins are phosphorylated downstream of ALK fusions in a manner that depends on ALK kinase activity (Chikamori et al, 2007). FRS binding and activation contributes to the transformation activity of NPM-ALK, possibly by stimulating MAP kinase or PI3K signaling, consistent with established roles in other pathways (reviewed in Palmer et al, 2009; Gotoh, 2008; Sato and Gotoh, 2010).

Literature References
PubMed ID Title Journal Year
19459784 Anaplastic lymphoma kinase: signalling in development and disease

Grabbe, C, Vernersson, E, Palmer, RH, Hallberg, B

Biochem. J. 2009
17086210 Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation

Yamamoto, T, Tokai-Nishizumi, N, Fujimoto, J, Chikamori, M

Oncogene 2007
19456272 The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment

Sato, T, Gotoh, N

Expert Opin Ther Targets 2009
18452557 Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins

Gotoh, N

Cancer Sci 2008
Participants
Participates
Catalyst Activity

protein tyrosine kinase activity of ALK fusions:FRS [cytosol]

Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!